Syncona says Achilles stake leaps to GBP145 million value after IPO Read More
DIRECTOR DEALINGS: Gym Group directors sell GBP1.8 million in shares Read More
Syncona invests USD42 million into Gyroscope to have 54% stake Read More
Syncona portfolio firm Achilles Therapeutics prices US share offering Read More
TRADING UPDATES: Origin Enterprises loss slims; Amryt issues guidance Read More
IN BRIEF: Syncona investee Achilles Therapeutics files for US IPO Read More
IN BRIEF: Syncona's Gyroscope Reports Positive Results From GT005 Test Read More
Syncona Net Asset Value Dips In Third Quarter, Invests More In Quell Read More
Syncona Investee Autolus Nets USD100 Million From ADS Offer Read More
Syncona Investee Freeline Modifies Hemophilia Plan After FDA Feedback Read More
Syncona Investee Achilles Reports Positive Trial Review, Mulling IPO Read More
Syncona Investee Autolus To Focus On Adult Leukemia Programme in 2021 Read More
UK EXECUTIVE CHANGE SUMMARY: Ferguson Taps Former Ashtead, Bunzl Execs Read More
Syncona Portfolio Companies Boost Interim Result; Launches New Company Read More
UK Earnings, Trading Statements Calendar - Next 7 Days Read More
UK EXECUTIVE CHANGE SUMMARY: Kakuzi Acts To Prevent Human Rights Abuse Read More
Syncona Investee Freeline Posts Widened Interim Loss On Higher Costs Read More
UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation Read More
Syncona Life Science Portfolio Boosted By Autolus And Freeline Read More
Syncona Investee Freeline Therapeutics Prices IPO In New York Read More
